523 related articles for article (PubMed ID: 23431153)
1. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
Britschgi A; Bill A; Brinkhaus H; Rothwell C; Clay I; Duss S; Rebhan M; Raman P; Guy CT; Wetzel K; George E; Popa MO; Lilley S; Choudhury H; Gosling M; Wang L; Fitzgerald S; Borawski J; Baffoe J; Labow M; Gaither LA; Bentires-Alj M
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E1026-34. PubMed ID: 23431153
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
[TBL] [Abstract][Full Text] [Related]
3. Researches of calcium-activated chloride channel ANO1 intervening amyotrophic lateral sclerosis progression by activating EGFR and CaMKII signaling.
Wang Y; Liang W; Wang T; Zhang C; Yang Y; Cong C; Wang X; Wang S; Wang D; Huo D; Wang H; Su X; Tan X; Feng H
Brain Res Bull; 2023 Nov; 204():110792. PubMed ID: 37858681
[TBL] [Abstract][Full Text] [Related]
4. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA
Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819
[TBL] [Abstract][Full Text] [Related]
5. The Ca(2+) -activated Cl(-) channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis.
Qu Z; Yao W; Yao R; Liu X; Yu K; Hartzell C
Cancer Med; 2014 Jun; 3(3):453-61. PubMed ID: 24639373
[TBL] [Abstract][Full Text] [Related]
6. Role of anoctamins in cancer and apoptosis.
Wanitchakool P; Wolf L; Koehl GE; Sirianant L; Schreiber R; Kulkarni S; Duvvuri U; Kunzelmann K
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130096. PubMed ID: 24493744
[TBL] [Abstract][Full Text] [Related]
7. Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment.
Wu H; Guan S; Sun M; Yu Z; Zhao L; He M; Zhao H; Yao W; Wang E; Jin F; Xiao Q; Wei M
PLoS One; 2015; 10(5):e0126128. PubMed ID: 25961581
[TBL] [Abstract][Full Text] [Related]
8. The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling.
Bill A; Alex Gaither L
Adv Exp Med Biol; 2017; 966():1-14. PubMed ID: 28293832
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.
Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J
Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851
[TBL] [Abstract][Full Text] [Related]
10. Role of ANO1 in tumors and tumor immunity.
Li H; Yu Z; Wang H; Wang N; Sun X; Yang S; Hua X; Liu Z
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2045-2068. PubMed ID: 35471604
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells.
Guan L; Song Y; Gao J; Gao J; Wang K
Oncotarget; 2016 Nov; 7(48):78619-78630. PubMed ID: 27732935
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer.
Jia L; Liu W; Guan L; Lu M; Wang K
PLoS One; 2015; 10(8):e0136584. PubMed ID: 26305547
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ca
Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
[TBL] [Abstract][Full Text] [Related]
14. Suppression of CaMKIIβ Inhibits ANO1-Mediated Glioblastoma Progression.
Sim KM; Lee YS; Kim HJ; Cho CH; Yi GS; Park MJ; Hwang EM; Park JY
Cells; 2020 Apr; 9(5):. PubMed ID: 32357567
[TBL] [Abstract][Full Text] [Related]
15. A mutual activation loop between the Ca
Wang H; Yao F; Luo S; Ma K; Liu M; Bai L; Chen S; Song C; Wang T; Du Q; Wu H; Wei M; Fang Y; Xiao Q
Cancer Lett; 2019 Jul; 455():48-59. PubMed ID: 31042586
[TBL] [Abstract][Full Text] [Related]
16. Small molecule-facilitated degradation of ANO1 protein: a new targeting approach for anticancer therapeutics.
Bill A; Hall ML; Borawski J; Hodgson C; Jenkins J; Piechon P; Popa O; Rothwell C; Tranter P; Tria S; Wagner T; Whitehead L; Gaither LA
J Biol Chem; 2014 Apr; 289(16):11029-11041. PubMed ID: 24599954
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression of HER2 by ANO1 Cl
Fujimoto M; Inoue T; Kito H; Niwa S; Suzuki T; Muraki K; Ohya S
Biochem Biophys Res Commun; 2017 Jan; 482(1):188-194. PubMed ID: 27838298
[TBL] [Abstract][Full Text] [Related]
18. TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
Kulkarni S; Bill A; Godse NR; Khan NI; Kass JI; Steehler K; Kemp C; Davis K; Bertrand CA; Vyas AR; Holt DE; Grandis JR; Gaither LA; Duvvuri U
Genes Chromosomes Cancer; 2017 Jun; 56(6):460-471. PubMed ID: 28177558
[TBL] [Abstract][Full Text] [Related]
19. ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.
Ayoub C; Wasylyk C; Li Y; Thomas E; Marisa L; Robé A; Roux M; Abecassis J; de Reyniès A; Wasylyk B
Br J Cancer; 2010 Aug; 103(5):715-26. PubMed ID: 20664600
[TBL] [Abstract][Full Text] [Related]
20. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression.
Duvvuri U; Shiwarski DJ; Xiao D; Bertrand C; Huang X; Edinger RS; Rock JR; Harfe BD; Henson BJ; Kunzelmann K; Schreiber R; Seethala RS; Egloff AM; Chen X; Lui VW; Grandis JR; Gollin SM
Cancer Res; 2012 Jul; 72(13):3270-81. PubMed ID: 22564524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
